AionWell’s current focus spans four connected capabilities: scientific evidence assessment; molecular and biomarker research, including antibody-based studies and assay development; preclinical molecular imaging; and integrated research program design.
Each capability page states the research questions it addresses, the methods involved, expected deliverables, and — just as explicitly — its scope and limitations.
Biological insight Decision-ready evidence
TE
Capability — 01
Translational Evidence and Research Strategy
Evaluate the strength, relevance, and limitations of existing biomedical evidence before committing to the next stage of therapeutic development. Deliverables may include an evidence map, structured scientific review, research gap assessment, and next-study recommendations.
MB
Capability — 02
Molecular Biomarker Research
Antibody-based research, molecular assays, and biomarker investigations to characterize disease-relevant mechanisms and generate evidence for therapeutic research — coordinated through participating research entities where specialized resources are required.
PI
Capability — 03
Preclinical Imaging
Investigate the distribution and biological behavior of appropriately designed probes and therapeutic candidates in living systems — probe research, quantitative imaging, biodistribution, and integrated interpretation.
IR
Capability — 04
Integrated Research
Evidence assessment, molecular experiments, imaging studies, and quantitative interpretation working together — scoped, coordinated, and reviewed around the decision that matters.
Current Capabilities
Described on these pages
The four capabilities above represent AionWell’s current focus. Specific methods, feasibility, and engagement scope are confirmed for each project before work begins.
Developing Technologies
AI-enabled scientific intelligence
We are developing AI-enabled approaches to make biomedical research evidence more structured, traceable, and useful for development decisions. These are in development and are not presented as a validated proprietary platform.
Long-Term Vision
Geroscience and healthy longevity
Aging biology and age-related disease research are a long-term scientific direction, labelled as emerging wherever they appear on this site.
Not sure which capability fits your question?
Start with the decision you are working toward. We can discuss which combination of evidence assessment, molecular research, and imaging is relevant.